The burgeoning popularity of semaglutide , initially for diabetes , is creating significant interest within the UK , prompting a notable shift in medication trends. Access these treatments remains a complex situation , with National Health Service coverage currently limited and specialist practices offering prescriptions at a higher cost . Question